CLVT Share Price Performance
US$3.66
-1.92 (-34.41%)
47.7% undervalued intrinsic discount
US$7.00
Fair Value
Price US$3.66
AnalystHighTarget US$7.00
AnalystConsensusTarget US$4.93
AnalystLowTarget US$3.75
Fair ValueUS$7.00
Share Pricen/a
Clarivate Plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
CLVT Community Narratives
AN
Fair Value US$7 47.7% undervalued intrinsic discount
Agentic AI And IP Platforms Will Empower Global Digital Transformation
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$4.93 25.8% undervalued intrinsic discount
Global Pharma And AI Trends Will Build Future Growth
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
Fair Value US$3.75 2.4% undervalued intrinsic discount
Rising Regulatory Costs And Data Erosion Will Undermine Future Performance
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Global Pharma And AI Trends Will Build Future Growth
Key Takeaways AI-driven product innovation and a subscription-based model are increasing customer retention, differentiation, and revenue stability across Clarivate's core segments. Portfolio optimization and expansion in global research demand support improved margins, free cash flow, and long-term shareholder returns.Read more
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
US$4.93
25.8% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
0.17% p.a.
Profit Margin
1.66%
Future PE
95.49x
Share price in 2028
US$6.87
Agentic AI And IP Platforms Will Empower Global Digital Transformation
Key Takeaways Rapid AI integration and platform adoption drive organic growth, improved retention, and sustained margin expansion, positioning Clarivate as a leader ahead of competitors. Strategic focus and portfolio streamlining enhance cash flow and earnings, enabling reinvestment and buybacks while benefiting from high customer dependence and rising global complexity.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$7
47.7% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
0.15% p.a.
Profit Margin
1.71%
Future PE
126.03x
Share price in 2028
US$9.48
Rising Regulatory Costs And Data Erosion Will Undermine Future Performance
Key Takeaways Evolving technology and freely available research are eroding Clarivate's market relevance, weakening its pricing power and pressuring revenue and margins. Regulatory challenges, customer dissatisfaction, and acquisition-heavy growth strategies are raising costs, increasing churn, and hindering sustainable profitability.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$3.75
2.4% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
-1.9% p.a.
Profit Margin
7.12%
Future PE
17.22x
Share price in 2028
US$5.08
Recently Updated Narratives
AN
Global Pharma And AI Trends Will Build Future Growth
Fair Value: US$4.93 25.8% undervalued intrinsic discount
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Regulatory Costs And Data Erosion Will Undermine Future Performance
Fair Value: US$3.75 2.4% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Agentic AI And IP Platforms Will Empower Global Digital Transformation
Fair Value: US$7 47.7% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Clarivate Plc Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.60
- 65.76%
- -15.83%
- 89.7%
About CLVT
- Founded
- 1864
- Employees
- 12000
- CEO
- WebsiteView website
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
